Disordered blood coagulation in burned children receiving high molecular weight dextran.
نویسندگان
چکیده
Coagulation studies were performed on nine children with burns. Four of these children received treatment which included intravenous dextran; all four showed abnormalities of coagulation and two of them developed a bleeding state. No abnormalities of haemostasis were detected in the remaining five children who had comparable degrees of burns but whose treatment did not include intravenous dextran.
منابع مشابه
Intravascular persistence and renal clearance of dextran of different molecular sizes in normal children.
During the past two decades dextran has been used extensively as a plasma volume expander in adults, while blood loss in the surgery of children is usually replaced by whole blood transfusion. Today the two main indications for using plasma expanders in children are in burns and other emergency situations when blood is not available. There is, however, increasing awareness of the complications ...
متن کاملThrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa.
To study the pathways for initiation of intrinsic blood coagulation, activated human platelets were compared with dextran sulfate as surfaces for factor XI activation by factor XIIa, factor XIa, or thrombin. Activated gel-filtered platelets promoted the activation of factor XI (60 nm) by thrombin (0.02-10 nm, EC(50) approximately 100 pm, threshold concentration approximately 10 pm) at initial r...
متن کاملWhen and where is factor XI activated by thrombin?
To the Editor. bound to the clot is protected and is no longer subject to inhibition by the competitive substrate, fibrinogen, and is able to catalyze the feedback to activate factor XI and enhance the intrinsic cascade. The pathway by which factor XI is initially activated is still unclear, because the autoactivation of factor is completely inhibited by fibrinogen and high molecular weight kin...
متن کاملLipoprotein-associated coagulation inhibitor (LACI) is a cofactor for heparin: synergistic anticoagulant action between LACI and sulfated polysaccharides.
Lipoprotein-associated coagulation inhibitor (LACI) is a plasma-derived protein that inhibits tissue factor (TF)/factor VIIa-induced coagulation in a factor Xa-dependent manner. The roles of endogenous plasma LACI and exogenously added LACI and heparin, in the regulation of coagulation, initiated via the intrinsic and extrinsic pathways, were studied using the activated partial thromboplastin t...
متن کاملThe effective oncotic pressure of dextran.
Measurement of plasma volume before and after the acute infusion of commercial dextran revealed that all brands tested were hyperoncotic by a factor of approximately 2. By mixing 6% dextran with 0.9% saline in 1:1 proportion a 3% dextran solution was obtained which was nearly isoncotic in our dogs. The most likely explanation for the discrepancy is that the 6% solution contains a high proportio...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of clinical pathology
دوره 25 6 شماره
صفحات -
تاریخ انتشار 1972